Effect of Perinatal Antiretroviral Drug Exposure on Hematologic Values in HIV‐Uninfected Children: An Analysis of the Women and Infants Transmission Study
about
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant womenIncreased Risk of Group B Streptococcus Invasive Infection in HIV-Exposed but Uninfected Infants: A Review of the Evidence and Possible MechanismsThe Immune System of HIV-Exposed Uninfected InfantsLinking Susceptibility to Infectious Diseases to Immune System Abnormalities among HIV-Exposed Uninfected InfantsHematological changes in women and infants exposed to an AZT-containing regimen for prevention of mother-to-child-transmission of HIV in TanzaniaMaternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir.Impact of maternal HIV-1 viremia on lymphocyte subsets among HIV-exposed uninfected infants: protective mechanism or immunodeficiency.Preventing and managing HIV infection in infants, children, and adolescents in the United States.The impact of maternal HIV infection on cord blood lymphocyte subsets and cytokine profile in exposed non-infected newborns.HIV-exposed infants: rethinking care for a lifelong condition.Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.Effect of Maternal HIV-1 Status and Antiretroviral Drugs on Haematological Profiles of South African Infants in Early Life.Cotrimoxazole prophylaxis and risk of severe anemia or severe neutropenia in HAART-exposed, HIV-uninfected infants.Increased risk of severe infant anemia after exposure to maternal HAART, Botswana.Increased risk of serious bacterial infections due to maternal immunosuppression in HIV-exposed uninfected infants in a European country.PedVacc 002: a phase I/II randomized clinical trial of MVA.HIVA vaccine administered to infants born to human immunodeficiency virus type 1-positive mothers in Nairobi.Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study).Severe Infections in HIV-Exposed Uninfected Infants Born in a European CountryAnemia and Red Blood Cell Abnormalities in HIV-Infected and HIV-Exposed Breastfed Infants: A Secondary Analysis of the Kisumu Breastfeeding Study.Altered Memory T-Cell Responses to Bacillus Calmette-Guerin and Tetanus Toxoid Vaccination and Altered Cytokine Responses to Polyclonal Stimulation in HIV-Exposed Uninfected Kenyan InfantsAntiretroviral Treatment Is Associated With Iron Deficiency in HIV-Infected Malawian Women That Is Mitigated With Supplementation, but Is Not Associated With Infant Iron Deficiency During 24 Weeks of Exclusive Breastfeeding.Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infantsTreatment Failures and Excess Mortality Among HIV-Exposed, Uninfected Children With PneumoniaCD4+/CD8+ T cell ratio for diagnosis of HIV-1 infection in infants: Women and Infants Transmission Study.Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design.African infants' CCL3 gene copies influence perinatal HIV transmission in the absence of maternal nevirapineHIV-exposed uninfected infants are at increased risk for severe infections in the first year of life.High levels of zidovudine (AZT) and its intracellular phosphate metabolites in AZT- and AZT-lamivudine-treated newborns of human immunodeficiency virus-infected mothersHematological Indices at Birth of Infants of HIV-Positive Mothers Participating in a Prevention of Mother-to-Child Transmission ProgramUpdate on successes and challenges regarding mother-to-child transmission of HIV.Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants.Infant growth outcomes after maternal tenofovir disoproxil fumarate use during pregnancy.Cancer Among Children With Perinatal Exposure to HIV and Antiretroviral Medications--New Jersey, 1995-2010.The HIV-exposed, uninfected African child.HIV-exposed uninfected children: a growing population with a vulnerable immune system?Adverse drug reactions associated with antiretroviral therapy during pregnancy.Tolerance of the newborn to antiretroviral drug exposure in utero.Cytomegalovirus viraemia is associated with poor growth and T-cell activation with an increased burden in HIV-exposed uninfected infants.Hematological alterations and thymic function in newborns of HIV-infected mothers receiving antiretroviral drugs.Pharmacogenomics and the prevention of mother-to-child transmission of HIV.
P2860
Q24236763-9D43623A-C57B-4590-8DD5-1933BA97ABA2Q28067423-A4C3EE38-4C27-40DF-A93B-0ADB3C829AB0Q28069872-50A5EEB7-8ED4-4497-8929-FA7C2659AB62Q28077904-A2F38A05-4AAC-456D-AB3D-EB29EDF25198Q28485996-210309BC-C0EA-49B1-8A48-501C669B9318Q33431825-BDD9A712-83A1-459A-97EC-979F930FB321Q33624111-01193003-4A1B-4B08-BAA8-6ABC7A3B0E99Q33808736-169AFB1B-7DA2-46D0-B5FC-D1639F0FFE61Q33811277-9BCB7971-6672-4E45-A99D-E16BBC21DC7BQ33871174-2C7442A7-16DE-4E15-AE94-859AD4783B1AQ34181048-4394BE9C-390B-421B-8A95-4A46919EF20EQ34508373-912FEC03-F305-4353-9273-56D9CFBFB235Q35004909-8084EA10-0AEB-4060-B309-7F9A124D44FCQ35037981-97418CA1-BE8F-4325-9FC3-36F5A86D1186Q35211424-A857043C-3DD2-4ED4-9E66-16157F9DB6FBQ35554825-D8A4AACF-5595-4498-AD8A-A254C436EE98Q35626381-693834BF-FD72-447E-8962-9F4FFA7711CAQ35748668-0D0374DD-4D1E-43AC-A45B-F9990B746E84Q35830556-31FD316C-D6C0-4CA6-90BC-F3E7D393E3F0Q35841753-EF214769-8C32-4E33-9B68-94C47D070C44Q35863995-DB37894E-B0F3-4277-AFBF-F310806EA77EQ36333957-CA288562-0D2D-4F72-8F89-0535632C8081Q36377376-1C515580-39AD-4789-BA88-EB5CD5DFCD02Q36425097-132E57A8-BB69-4737-B4BE-74B88E54DA01Q36438846-B8D4B01C-14A5-4595-85F9-AD1D780BB01BQ36662927-F976E7FA-26AE-40A2-8CB9-85139E2C2D0EQ36727938-F8BA5179-0DD1-4318-941B-6696DB04C507Q36744874-8E087318-D4E9-44A5-8C63-0F0369A47337Q36967119-9B102885-637C-4666-A843-82393432619BQ37116460-F0720A12-C7C4-44DE-B44B-85601C6E3687Q37148266-00BD81C3-BB1B-4CDC-9D2B-203ECB6F4211Q37283062-84DEBAA1-F835-4300-89A6-21FAEF926C40Q37326056-3E191270-FE58-48A3-983C-AAAB5A32EE03Q37378079-C55DB34E-6A96-4F08-8E2E-65FD84516760Q38170189-B9017E81-7FC9-47E2-9D6B-CAFC11FC03EFQ38267557-B358B223-D26B-4B65-A30B-28DFB622DDC0Q38366365-A1F27A50-DD5E-43C8-85B9-4DC0FD98C40BQ39017322-B8199C1E-4DE0-44E7-9859-F9EA42019425Q42270661-2A2EC102-C957-46EA-A879-9310CC37F5B7Q43450646-09A418D8-6223-44D5-9E44-45204BF0F32B
P2860
Effect of Perinatal Antiretroviral Drug Exposure on Hematologic Values in HIV‐Uninfected Children: An Analysis of the Women and Infants Transmission Study
description
article
@en
im September 2006 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2006
@uk
name
Effect of Perinatal Antiretrov ...... and Infants Transmission Study
@en
Effect of Perinatal Antiretrov ...... and Infants Transmission Study
@nl
type
label
Effect of Perinatal Antiretrov ...... and Infants Transmission Study
@en
Effect of Perinatal Antiretrov ...... and Infants Transmission Study
@nl
prefLabel
Effect of Perinatal Antiretrov ...... and Infants Transmission Study
@en
Effect of Perinatal Antiretrov ...... and Infants Transmission Study
@nl
P2093
P356
P1476
Effect of perinatal antiretrov ...... and infants transmission study
@en
P2093
Clemente Diaz
Edward Handelsman
Karen Hayani
Kenneth McIntosh
Margaret Frederick
Susan E Pacheco
Women and Infants Transmission Study
P304
P356
10.1086/507645
P407
P577
2006-09-11T00:00:00Z